Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Commentary & Deal Flow

PRICED: Italmatch E690m sr sec 2-part, E300m 5NC2 fixed 6.25% at 100, E390m 5NC1 FRN at E+412.5bp at 100

HYC European Market: Deal Flow - General

Italmatch Chemicals SpA (FIREBC) EUR690m 144A/Reg S sr sec notes two-part. B2/B/ B (stable/stable/stable). Via BNP/GS (B&D) jt physical books/Citi/CA/UniCredit  jt glocos and jt books. No reg rights. List Lux. NY law. CoC at 101. Denoms: 100kx1k. Settles 02/05 (T+5).


    - EUR300m (from EUR300m minimum) fixed rate notes due 02/05/31 (5y). NC2 (02/05/28) (MWC B+50bp), then at 103.125 02/05/28, 101.563 02/05/29, 100 02/05/30. Equity claw: 2y 40% at 106.25. Special call: 10% per year the first 2 years at 103.00. Pays June 30 and Dec 31, starting 06/30/26 (30/360). Reg S ISIN: XS3282797383. IPT high 6%-7%. Price talk: 6.50% area (+/- 0.125%). Final terms: EUR300m at 6.25%. Priced: 6.25% at 100. +387bp vs DBR 0.00% 02/15/31.


    - EUR390m (from EUR300m minimum) FRN due 02/05/31 (5y). NC1 (02/05/27) (MWC B+50bp), then at 100. Pays March 31, June 30, Sept 30, Dec 31, starting 06/30/26 (Act/365). Reg S ISIN: XS3282799165. IPT: low-to-mid E+400s. Price talk: E+425bp area (+/- 12.5bp). Final terms: EUR390m at E+412.5bp. Priced: 3mE+412.5bp (0% floor) at 100.


Roadshow (small group meetings) 01/26-28 (investor call at 11:30am UKT 01/26). Books closed at 1pm UKT (from 12pm UKT) 01/29. UOP: along with EUR18m cash on hand, to redeem its EUR390m sr sec FRN due 02/06/28 (callable at 100) and EUR300m 10% sr sec notes due 02/05/28 (callable at 102.50 on 02/06/26). Equity sponsor: Bain. Biz: leading global specialty chemicals manufacturer. HQ: Genoa, Italy.


DealRoadshow direct link: https://dealroadshow.com/e/ITALMATCH26. Entry code: ITALMATCH26.


We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.